GoldBamboo.com - Knowledge is strong medicine
  

Heart Disease Risk Factors in Major Depression - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Adrenal Gland Disorders

Adrenal Disease; Disorder 




Clinical Trial: Heart Disease Risk Factors in Major Depression

This study is currently recruiting patients.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: Warren G Magnuson Clinical Center (CC)

Purpose

The purpose of this study is to understand why depressed people have a greater chance of developing heart disease than people who are not depressed. This study will examine insulin resistance in participants with major depression to determine how severe it is and why it occurs.

People with major depression have an increased risk for coronary artery disease. This increased risk may be a result of hormonal changes that occur with depression. Insulin resistance may be associated with these hormonal changes. This study will determine whether insulin resistance is an underlying mechanism that predisposes people with major depression to ischemic heart disease.

Participants will be screened with a medical and psychiatric history, a physical examination, blood and urine tests, and an electrocardiogram. A control group of healthy volunteers will also be recruited as a comparison group.

Condition
Adrenal Gland Hyperfunction
Cardiovascular Disease
Involutional Depression

MedlinePlus related topics:  Adrenal Gland Disorders;   Heart Diseases;   Mental Health;   Vascular Diseases

Study Type: Observational
Study Design: Natural History

Official Title: Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients with Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp

Further Study Details: 

Expected Total Enrollment:  80

Study start: December 30, 1999

A series of studies in patients with major depression have consistently demonstrated a doubling of the mortality rate at any age, independent of suicide. In addition, the relative risk for clinically significant coronary artery disease in patients with major depression is also 2 or even higher in studies that are independently controlled for risk factors such as smoking, hypertension, etc. The principal long-term goals of the CNE include the determination of the mechanisms that underlie enhanced susceptibility to premature ischemic heart disease in patients with major depression, documenting the age at which demonstrable pathophysiologic or predictive changes begin to occur, and charting their rate of progression. Our long-term goal is to use our understanding of underlying mechanisms to enhance our capacity to predict who with major depression is most likely to develop premature ischemic heart disease, to determine the age of this susceptibility, and to develop improved means for treatment and prevention. While there are numerous risk factors for coronary artery disease and we plan to study them as well in our serial protocols, in this protocol, we propose to study insulin resistance as an underlying mechanism that predisposes patients with major depression to ischemic heart disease.

Eligibility

Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

INCLUSION CRITERIA:
Men and women, from all ethnic backgrounds, between 18 and 65 years old who have had a history of any types of major depression or are currently depressed will be eligible for this study, provided they are free from the conditions described in the exclusion criteria. Candidates will be screened with a complete medical and psychiatric history and physical examination, as well as blood and urine tests, and electrocardiogram. Healthy volunteers will also be recruited to this study to serve as a control group. Volunteers will be matched to each patient in the study according to age, gender, body weight and height, and will undergo the same screening and study procedures.
Females must not be pregnant.
Subjects must not have diabetes mellitus.
Subjects must not have cardiovascular, renal, hepatic and other end organ diseases.
Subjects must not have peripheral vascular disease.
Subjects must not have any inflammatory diseases.
Subjects must not have HIV infection.
Subjects must not be on beta-blockers, thiazides, and/or glucocorticoids.
Subjects must have BMI of 29 or less.

Location and Contact Information


Maryland
      National Institute of Mental Health (NIMH), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting
Patricia M. Kasdan  3014967290    kasdanp@mail.nih.gov 

More Information

Detailed Web Page

Publications

Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O'Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996 Sep 15;78(6):613-7.

Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998 Jan;155(1):4-11. Review.

Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA. 1990 Sep 26;264(12):1541-5.

Study ID Numbers:  000049; 00-M-0049
Record last reviewed:  November 4, 2003
Last Updated:  November 23, 2004
Record first received:  January 18, 2000
ClinicalTrials.gov Identifier:  NCT00001969
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Adrenal Gland Disorders.

November 28, 2009



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.